-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$38.80162.16% Upside
Day One Biopharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Day One Biopharmaceuticals, Inc.?
Day One Biopharmaceuticals, Inc. has been rated by research analysts at Bank of America Securities, H.C. Wainwright, Piper Sandler, Needham, Goldman Sachs in the past 90 days.